Literature DB >> 23425199

Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors.

Alessio Lodola1, Luigi Capoferri, Silvia Rivara, Giorgio Tarzia, Daniele Piomelli, Adrian Mulholland, Marco Mor.   

Abstract

Carbamate and urea derivatives are important classes of fatty acid amide hydrolase (FAAH) inhibitors that carbamoylate the active-site nucleophile Ser241. In the present work, the reactivation mechanism of carbamoylated FAAH is investigated by means of a quantum mechanics/molecular mechanics (QM/MM) approach. The potential energy surfaces for decarbamoylation of FAAH covalent adducts, derived from the O-aryl carbamate URB597 and from the N-piperazinylurea JNJ1661610, were calculated and compared to that for deacylation of FAAH acylated by the substrate oleamide. Calculations show that a carbamic group bound to Ser241 prevents efficient stabilization of transition states of hydrolysis, leading to large increments in the activation barrier. Moreover, the energy barrier for the piperazine carboxylate was significantly lower than that for the cyclohexyl carbamate derived from URB597. This is consistent with experimental data showing slowly reversible FAAH inhibition for the N-piperazinylurea inhibitor and irreversible inhibition for URB597.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23425199      PMCID: PMC3724458          DOI: 10.1021/jm301867x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  62 in total

1.  Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.

Authors:  Giulia Palermo; Davide Branduardi; Matteo Masetti; Alessio Lodola; Marco Mor; Daniele Piomelli; Andrea Cavalli; Marco De Vivo
Journal:  J Med Chem       Date:  2011-09-08       Impact factor: 7.446

Review 2.  The endocannabinoid system: a drug discovery perspective.

Authors:  Daniele Piomelli
Journal:  Curr Opin Investig Drugs       Date:  2005-07

Review 3.  Fatty acid amide hydrolase: from characterization to therapeutics.

Authors:  Geoffray Labar; Catherine Michaux
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

4.  Elucidation of hydrolysis mechanisms for fatty acid amide hydrolase and its Lys142Ala variant via QM/MM simulations.

Authors:  Ivan Tubert-Brohman; Orlando Acevedo; William L Jorgensen
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

5.  Application of a SCC-DFTB QM/MM approach to the investigation of the catalytic mechanism of fatty acid amide hydrolase.

Authors:  Luigi Capoferri; Marco Mor; Jitnapa Sirirak; Ewa Chudyk; Adrian J Mulholland; Alessio Lodola
Journal:  J Mol Model       Date:  2011-03-02       Impact factor: 1.810

6.  Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties.

Authors:  M P Patricelli; M A Lovato; B F Cravatt
Journal:  Biochemistry       Date:  1999-08-03       Impact factor: 3.162

7.  Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain.

Authors:  Kay Ahn; Sarah E Smith; Marya B Liimatta; David Beidler; Nalini Sadagopan; David T Dudley; Tim Young; Paul Wren; Yanhua Zhang; Steven Swaney; Keri Van Becelaere; Jacqueline L Blankman; Daniel K Nomura; Shobha N Bhattachar; Cory Stiff; Tyzoon K Nomanbhoy; Eranthie Weerapana; Douglas S Johnson; Benjamin F Cravatt
Journal:  J Pharmacol Exp Ther       Date:  2011-04-19       Impact factor: 4.030

Review 8.  Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.

Authors:  Séverine Vandevoorde
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

9.  Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Authors:  Marco Mor; Silvia Rivara; Alessio Lodola; Pier Vincenzo Plazzi; Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Giovanni Piersanti; Satish Kathuria; Daniele Piomelli
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

Review 10.  Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.

Authors:  Benjamin F Cravatt; Aron H Lichtman
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

View more
  7 in total

1.  O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.

Authors:  Giampiero Colombano; Clara Albani; Giuliana Ottonello; Alison Ribeiro; Rita Scarpelli; Glauco Tarozzo; Jennifer Daglian; Kwang-Mook Jung; Daniele Piomelli; Tiziano Bandiera
Journal:  ChemMedChem       Date:  2014-10-22       Impact factor: 3.466

2.  Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency.

Authors:  Francesca Galvani; Laura Scalvini; Silvia Rivara; Alessio Lodola; Marco Mor
Journal:  J Chem Inf Model       Date:  2022-05-17       Impact factor: 6.162

3.  Testing Affordable Strategies for the Computational Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2 3CL Protease Inhibition.

Authors:  Carlos A Ramos-Guzmán; José Luis Velázquez-Libera; J Javier Ruiz-Pernía; Iñaki Tuñón
Journal:  J Chem Theory Comput       Date:  2022-05-13       Impact factor: 6.578

4.  Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets.

Authors:  Giulia Palermo; Inga Bauer; Pablo Campomanes; Andrea Cavalli; Andrea Armirotti; Stefania Girotto; Ursula Rothlisberger; Marco De Vivo
Journal:  PLoS Comput Biol       Date:  2015-06-25       Impact factor: 4.475

5.  N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.

Authors:  Naresh Sunduru; Mona Svensson; Mariateresa Cipriano; Sania Marwaha; C David Andersson; Richard Svensson; Christopher J Fowler; Mikael Elofsson
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

6.  Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors.

Authors:  Sean D Kodani; Debin Wan; Karen M Wagner; Sung Hee Hwang; Christophe Morisseau; Bruce D Hammock
Journal:  ACS Omega       Date:  2018-10-25

7.  Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide.

Authors:  Alessia D'Aloia; Federica Arrigoni; Renata Tisi; Alessandro Palmioli; Michela Ceriani; Valentina Artusa; Cristina Airoldi; Giuseppe Zampella; Barbara Costa; Laura Cipolla
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.